Key Market Indicators
By 2026, the prevalence of HIV/AIDS among children aged 0-14 in Senegal is predicted to drop to 3,480 units (persons), a 2.2% decrease from the 2021 figure of 3,890 units (persons). Since 1995, the prevalence has decreased by 5.3% on an annual basis. In 2021, Senegal was ranked 39th, behind Uzbekistan, which had 3,890 units (persons). Nigeria, Mozambique and Tanzania were second, third and fourth, respectively. Senegal's treatment coverage for people living with HIV jumped 5.2 points from 2020 to 2021, from 77% to 81%. Since 2012, the coverage has increased by 9.7 points annually. In 2021, Senegal was ranked 35th, with Ethiopia ahead at 81%. Cape Verde, Latvia and Zimbabwe were second, third and fourth, respectively.
Senegal HIV AIDS Market Data and Forecasts
How much will Senegal HIV AIDS Market grow to 2026?
More in HIV AIDS Industry for 2028Improve your Knowledge with the latest Indicators and Trends
-
HIV Treatment Sector: Comprehensive Analysis of Therapeutic Advancements and Opportunities
The modern HIV treatment landscape has been remodelled by the introduction of revolutionary drugs and therapeutic interventions focusing on improved patient compliance and reduced side effects. Antiretroviral therapy (ART) has notably evolved, with a surge of new drug categories, such as integrase inhibitors, showing remarkable efficacy. There has also been...
Discover more insights -
HIV Market Access Impact: Influential Points & Comprehensive Perspectives
The influence within the HIV market is primarily driven by multiple factors. Key among them includes the level of pharmaceutical innovation, the prevalence of the disease, and the nature of funding for treatment and research. Pharmaceutical companies have been more amicable towards investing in the development of groundbreaking treatments, paving...
Discover more insights